UNIVERSITY OF BASEL
Patent Owner
Stats
- 28 US PATENTS IN FORCE
- 5 US APPLICATIONS PENDING
- Mar 01, 2018 most recent publication
Details
- 28 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 606 Total Citation Count
- Sep 30, 1993 Earliest Filing
- 17 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2017/0299,570 METHOD FOR PREDICTING CANCER PROGRESSION BY NANOMECHANICAL PROFILINGOct 05, 15Oct 19, 17[G01N, G01Q]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9500670 Method and device for controlling a scanning probe microscopeDec 12, 13Nov 22, 16[B82Y, G01Q]
9244095 Method and device for controlling a scanning probe microscopeDec 12, 12Jan 26, 16[B82Y, G01Q]
9028820 Antibodies against tropomyosin-related kinase B receptorsMay 18, 12May 12, 15[A61K, C12N, C07K]
8993244 Screening for compounds having immunosuppressant activity by testing impact on leukocyte-specific calcium fluxesMar 12, 09Mar 31, 15[G01N]
8993587 Combination of syrosingopine and mitochondrial inhibitors for the treatment of cancer and immunosuppressionJan 09, 12Mar 31, 15[A61K]
8921361 Triazine, pyrimidine and pyridine analogs and their use as therapeutic agents and diagnostic probesNov 10, 09Dec 30, 14[A61K, C07D]
8841073 Methods for identifying RNA segments bound by RNA-binding proteins or ribonucleoprotein complexesJul 28, 09Sep 23, 14[C07H, C12Q]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2013/0040,912 PIPERAZINOTRIAZINES AS PI3K INHIBITORS FOR USE IN THE TREATMENT ANTIPROLIFERATIVE DISORDERSAbandonedApr 27, 11Feb 14, 13[A61K, C07F, C07D, G01N, A61P]
2013/0040,934 SPIROCYCLIC COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS AND DIAGNOSTIC PROBESAbandonedMar 11, 11Feb 14, 13[A61K, C12N, C07D, A61P]
2012/0270,824 MANNOSE DERIVATIVES AS ANTAGONISTS OF BACTERIAL ADHESIONAbandonedDec 13, 10Oct 25, 12[A61K, C07H, A61P]
2012/0107,938 METHODS AND KITS FOR HIGH EFFICIENCY ENGINEERING OF CONDITIONAL MOUSE ALLELESAbandonedJun 28, 10May 03, 12[C12N]
8084258 Manipulation of tissue of organ type using the notch pathwayExpiredJan 05, 04Dec 27, 11[C12N]
2010/0239,535 METHOD FOR ISOLATING HOMOGENEOUS POPULATIONS OF TRANSDUCED PROGENITORS STABLY EXPRESSING SPECIFIC LEVELS OF A TRANSGENEAbandonedMay 16, 07Sep 23, 10[A61K, C12N, G01N, A61P]
2010/0227,772 DETERMINING THE INTERACTION BETWEEN NUCLEIC ACIDS AND NUCLEIC ACID BINDING MOLECULESAbandonedNov 16, 07Sep 09, 10[G01N, C40B]
7657133 Single analyte molecule detection by fibre fluorescence probeExpiredAug 18, 05Feb 02, 10[G02B]
2009/0239,760 Method for the Identification of New Leads for Drug CandidatesAbandonedMar 14, 07Sep 24, 09[C40B]
2009/0121,148 High Brightness Solid State Ion Beam Generator, its use, and Method for Making such a GeneratorAbandonedMar 29, 06May 14, 09[H01J]
2005/0287,208 Cross-linked powered/microfibrillated cellulose IIAbandonedJun 22, 05Dec 29, 05[A61K, C08B]
2005/0222,639 Translational sensory stimulation procedure for the stimulation of amygdala-hippocampal complexAbandonedFeb 22, 05Oct 06, 05[A61N]
6947311 Two-dimensional structural transition controlled by an electric field, memory storage device thereof, and method of making a memory storage deviceExpiredJun 09, 04Sep 20, 05[G11B, G11C]
2005/0118,601 Enhancer sequence of the 5-aminolevulinic acid synthase geneAbandonedOct 08, 04Jun 02, 05[C07H, C12Q, C07K]
2004/0137,464 Parallel analysis of single nucleotide polymorphismsAbandonedJul 22, 03Jul 15, 04[C12Q, C12P]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.